Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A
KNSA
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.81B
Close$
$66.80
6.3% upsideKiniksa Pharmaceuticals International Plc. Target Price Details
Target Price by Analysts
6.3% upsideKiniksa Pharmaceuticals International Plc. Target Price Details$-4.53
107.2% downside
Current Fair Value
107.2% downsideOvervalued by 107.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.81 Billion |
|---|---|
| Enterprise Value | $4.63 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.8 |
| Beta | 0.07 |
| Outstanding Shares | 76,516,535 |
Return
| Return on Equity | 12.06% |
|---|---|
| Return on Assets | 8.85% |
| Return on Invested Capital | 14.52% |
Valuation & Multiples
| P/E Ratio | 65.26 |
|---|---|
| PEG | 39.65 |
| Price to Sales | 6.98 |
| Price to Book Ratio | 8.98 |
| Enterprise Value to Revenue | 6.14 |
| Enterprise Value to EBIT | 47.66 |
| Enterprise Value to Net Income | 63 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 5, 2026
EPS Estimate
$0.18
Average shareholder expectationRevenue Estimate
$207.12 M
Average shareholder expectationNext Earnings Call
Expected Date
July 28, 2026
EPS Estimate
$0.30
Average shareholder expectationRevenue Estimate
$226.49 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 2.20% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.49%▼ 60.70% |
|---|---|
| Total Invested | $23.98M▼ 98.90% |
| Investors Holding | 22▼ 212.00% |
ESG Score
No data